Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ESWT Imorove Pain and Function in Carpal Tunnel

NCT: NCT06214286 · COMPLETED

NCT IDNCT06214286
StatusCOMPLETED
Start Date2024-04-10
Completion2024-11-20

Brief Summary

PURPOSE: To investigate the effect of adding Shock wave therapy to kinesio taping on relieving carpal tunnel syndrome symptoms in physical therapist females. BACKGROUND: shockwave therapy is a popular non-invasive therapeutic modality in the medical field for the treatment of numerous musculoskeletal disorders. Shockwaves can generate interstitial and extracellular responses, producing many beneficial effects such as: pain relief, vascularization, protein biosynthesis, cell proliferation, neuro and chondroprotection, and destruction of calcium deposits in musculoskeletal structures. shockwave combined with conventional physiotherapy is an effective noninvasive treatment for mild-to-moderate carpal tunnel syndrome that produces greater and longer-lasting results than conventional physiotherapy alone HYPOTHESES: Adding Shock wave therapy to kinesio taping has positive effects on carpal tunnel syndrome in physical therapist females. RESEARCH QUESTION: Does adding Shock wave therapy to kinesio taping has positive effects on carpal tunnel syndrome in physical therapist females?

Frequently Asked Questions

What is ESWT Imorove Pain and Function in Carpal Tunnel?

ESWT Imorove Pain and Function in Carpal Tunnel is a clinical trial registered under NCT06214286. Current status: COMPLETED.

What is the status of NCT06214286?

The current status of NCT06214286 (ESWT Imorove Pain and Function in Carpal Tunnel) is: COMPLETED.

When did ESWT Imorove Pain and Function in Carpal Tunnel start?

ESWT Imorove Pain and Function in Carpal Tunnel started on 2024-04-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.